Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability.
about
Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothelial cellscGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytesMicrovascular permeability.Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptideAcute and chronic exposure to shear stress have opposite effects on endothelial permeability to macromoleculesIntracellular signalling involved in modulating human endothelial barrier function.Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-ANitric oxide function in atherosclerosisRegulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases.Everything we always wanted to know about furosemide but were afraid to ask.Nitric oxide synthase inhibition causes acute increases in glomerular permeability in vivo, dependent upon reactive oxygen species.Dominant role of cAMP in regulation of microvessel permeability.Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure.The Janus-faced regulation of endothelial permeability by cyclic GMP.Nitric oxide production by glomerular podocytes.The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs.
P2860
Q22010143-3E85861C-DB99-4154-8C1C-76DF9F85112BQ24561615-35046CFA-556A-49A6-8858-609BB0442EE4Q33676895-9EEF6B36-DE4B-42B7-96D8-95EB746A4665Q33831907-7648476E-5F73-42E7-84BD-22416A0F455DQ33917169-9D5F1FCC-FBCF-453C-AB36-AFBE826FA111Q34773995-3D36E48D-F9DD-4BA2-967E-65005710A3BAQ36599906-24AB3788-11B9-45C3-99C5-018B78A39ED9Q36628207-79411F85-847C-4780-AC94-9051570A5AFBQ37893065-0F78EF1B-4D12-49DB-BFAA-6D65F264917EQ38748880-A6E51419-5630-4679-B608-BFCFD3A9D289Q39342881-456F001F-9E3E-40F7-9C20-1A4579740083Q41728380-A3C034D5-C45B-4D74-BE49-B6B16554A2F7Q44391188-EE5092F5-134C-4F98-A4F9-580E21EF19FDQ48646587-DE78EA09-EE8D-4F4B-82C4-F90C987E36E7Q50058377-14C14C1B-DEDA-4D83-973D-0AC282920B2EQ52540627-460D3EA8-15C3-45F6-80CA-302AEEE09E46
P2860
Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@en
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@nl
type
label
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@en
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@nl
prefLabel
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@en
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@nl
P2093
P2860
P1476
Role of nitric oxide and phosp ...... endothelial hyperpermeability.
@en
P2093
M Fuhrmann
S Hippenstiel
T Podzuweit
P2860
P304
P356
10.1152/AJPCELL.1996.270.3.C778
P407
P433
P577
1996-03-01T00:00:00Z